CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AB6. A total of 28 filers reported holding CLOVIS ONCOLOGY INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $7,139,000 | -10.9% | 6,138,000 | +3.5% | 0.02% | -8.7% |
| Q4 2017 | $8,009,000 | -59.6% | 5,930,000 | -53.8% | 0.02% | -60.3% |
| Q3 2017 | $19,835,000 | -35.9% | 12,828,000 | -29.7% | 0.06% | -37.0% |
| Q2 2017 | $30,967,000 | +68.1% | 18,243,000 | +28.0% | 0.09% | +67.3% |
| Q1 2017 | $18,417,000 | +207.3% | 14,249,000 | +298.1% | 0.06% | +205.6% |
| Q3 2015 | $5,993,000 | – | 3,579,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINDEN ADVISORS LP | 84,846,000 | $114,699,000 | 3.39% |
| SYMPHONY ASSET MANAGEMENT LLC | 6,000,000 | $8,104,000 | 0.82% |
| ZAZOVE ASSOCIATES LLC | 10,100,000 | $13,682,000 | 0.81% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 14,074,000 | $19,008,000 | 0.54% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 5,000,000 | $6,728,000 | 0.43% |
| CSS LLC/IL | 6,251,000 | $8,433,000 | 0.42% |
| SSI INVESTMENT MANAGEMENT LLC | 3,032,000 | $4,080,000 | 0.34% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 7,328,000 | $9,903,000 | 0.19% |
| Nicholas Investment Partners, LP | 1,620,000 | $2,180,000 | 0.07% |
| D. E. Shaw & Co., Inc. | 34,550,000 | $46,670,000 | 0.06% |